Health Catalyst Capital Management

About The Fund

Health Catalyst Capital Management (HCC) is a venture capital firm based in New York, New York, founded in 2015. They focus on investments in the healthcare sector, particularly in high-growth healthcare information technology and technology-enabled services businesses. HCC's investment thesis centers on the premise that technological solutions will be required to enhance the quality of care, increase access, and improve affordability within the U.S. healthcare system, which they view as a non-cyclical market with an annual spend of over $4 trillion. They target the lower middle market where they believe their operational experience and industry expertise can have the greatest impact, and where there are significant growth prospects and potential for capital appreciation. Their approach to investments includes infusing operational expertise and working closely with the companies they invest in to realize their full potential. The investor base of HCC comprises large healthcare organizations, institutional investors, family offices, healthcare entrepreneurs, and senior executives, reflecting a diverse group of stakeholders committed to advancing healthcare innovation. HCC's portfolio reflects their commitment to this sector, and they aim to contribute to transforming healthcare delivery through their strategic investments, with a uniform investment size of $1,500,000. The firm's focus industries include IT and TMT, BioTech, HealthTech and Fitness, and Life Science, reflecting a broad engagement across the various subsectors of healthcare.